GALLO CANTAFIO, MARIA EUGENIA
 Distribuzione geografica
Continente #
NA - Nord America 456
EU - Europa 238
AS - Asia 227
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
AF - Africa 2
OC - Oceania 2
Totale 934
Nazione #
US - Stati Uniti d'America 443
SG - Singapore 179
IT - Italia 157
GB - Regno Unito 23
CN - Cina 21
SE - Svezia 17
CA - Canada 12
HK - Hong Kong 9
FI - Finlandia 8
DE - Germania 7
IN - India 7
CZ - Repubblica Ceca 5
EU - Europa 5
YE - Yemen 5
NL - Olanda 4
CH - Svizzera 3
RO - Romania 3
RU - Federazione Russa 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
BR - Brasile 2
EG - Egitto 2
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
CL - Cile 1
ES - Italia 1
FR - Francia 1
GR - Grecia 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 934
Città #
Singapore 89
Chandler 83
Santa Clara 42
Catanzaro 35
Chicago 25
Lawrence 23
Princeton 23
London 22
Milan 21
Ashburn 13
Wilmington 11
Des Moines 9
Hong Kong 9
Ottawa 9
Turku 8
Boardman 6
San Nicola Manfredi 6
Bari 5
Olomouc 5
Reggio Calabria 5
Sanaa 5
The Dalles 5
Cosenza 4
Naples 4
Rome 4
Siano 4
Ahmedabad 3
Berlin 3
Brooklyn 3
Castrovillari 3
Chennai 3
Los Angeles 3
Munich 3
Norwalk 3
Redwood City 3
San Antonio 3
6th of October City 2
Ceglie Del Campo 2
Cortale 2
Grottaglie 2
Horia 2
Irsina 2
New York 2
Redmond 2
Roccella Ionica 2
San Francisco 2
San Polo di Torrile 2
Santo Stefano di Rogliano 2
Settingiano 2
Shanghai 2
Shantou 2
São Paulo 2
Vallefiorita 2
Vienna 2
Amsterdam 1
Apo 1
Augusta 1
Bern 1
Buffalo 1
Calgary 1
Catania 1
Changchun 1
Charlotte 1
Clearwater 1
Decollatura 1
Dhaka 1
East Lansing 1
Fidenza 1
Giugliano in Campania 1
Kansas City 1
Lahore 1
Lamezia Terme 1
Leawood 1
Melbourne 1
Mexico City 1
Nanjing 1
Oberwil 1
Palermo 1
Paris 1
Parma 1
Phoenix 1
Pune 1
Roccella Jonica 1
Shenzhen 1
South Woodstock 1
Toronto 1
Vancouver 1
Warsaw 1
Zhenjiang 1
Totale 576
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 77
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 61
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 49
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 45
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 45
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 42
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 40
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 37
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 31
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths 31
null 31
MiR-34a Replacement As a Novel Therapeutic Approach for Multiple Myeloma: Preclinical In Vitro and In Vivo Evidence 31
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 30
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 29
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 28
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 26
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 26
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates 25
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 24
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 21
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 18
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 17
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 17
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 16
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model 16
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 16
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 15
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence 15
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma 13
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 13
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma 13
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo 13
Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma 13
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 11
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity 10
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 9
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 9
Lipid metabolic vulnerabilities of multiple myeloma 8
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells 7
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors 6
Lipid metabolic vulnerabilities of multiple myeloma 6
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 5
null 1
Totale 996
Categoria #
all - tutte 12.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 0 3 10
2020/202173 3 0 8 5 9 3 6 5 16 18 0 0
2021/202295 0 0 0 15 6 4 9 14 13 19 14 1
2022/2023250 46 16 18 10 27 23 3 19 41 15 18 14
2023/2024142 36 26 5 11 7 33 5 0 0 1 7 11
2024/2025399 54 17 20 25 29 76 26 15 44 39 54 0
Totale 996